Zacks upgraded shares of Kindred Healthcare (NYSE:KND) from an underperform rating to a neutral rating in a research note released on Tuesday morning, Analyst Ratings Network.com reports. They currently have $17.90 target price on the stock. Zacks has also updated their ratings on a number of other healthcare stocks in the last week. The firm […]
Kindred Healthcare Rating Increased to Neutral at Zacks (KND) is a post from: Zolmax
The post Kindred Healthcare Rating Increased to Neutral at Zacks (KND) appeared first on Zolmax.